St Louis Trust’s Boston Scientific BSX Stock Holding History

St Louis Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,214	Closed	-$641K	–	131
2026 Q1	$641K	Buy	10,214 +1,279	+14%	+$102K	0.07%	102
2025 Q4	$852K	Buy	+8,935	New	+$876K	0.1%	94

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

St Louis Trust's BSX Position: Q2 2026 in Review

St Louis Trust sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 10,214 shares — an estimated $641K sold.

St Louis Trust first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $852K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

St Louis Trust reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
St Louis Trust sold 10,214 Boston Scientific shares in Q2 2026, an estimated $641K.
St Louis Trust first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
St Louis Trust's Boston Scientific position peaked at $852K in Q4 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on St Louis Trust's 13F filing for Q2 2026, filed 30 Jul 2026.